Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162
Dementia01:30

Dementia

94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
94

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroids with or without antiviral therapy in elderly patients hospitalized with COVID-19 during the Omicron era: A multicenter real-world study.

Journal of virus eradication·2026
Same author

Antimicrobial resistance patterns and genomic characterization of Avibacterium paragallinarum isolates collected in China from 2013 to 2021.

BMC microbiology·2026
Same author

Self-charged polar nematic monopoles and hybrid topological states: intertwining and domain integration.

Nature communications·2026
Same author

Seepage analysis of tunnel lining under the synergistic effect of cave-fracture networks in water-rich karst formations.

Scientific reports·2026
Same author

Changes in aperiodic EEG activity following acupuncture stimulation in stroke.

Cognitive neurodynamics·2026
Same author

[Paradigm breakthrough in postgraduate training of acupuncture professional master's degree in modern AI-driven medical scenes].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2026
Same journal

Human-AI Interaction in Interventional Radiology: A Narrative Review of Current Applications, Challenges, and Future Directions.

Journal of imaging·2026
Same journal

Coronary Artery Anomalies and Anatomical Variants: Cross-Sectional Diagnostic Imaging and Clinical Background.

Journal of imaging·2026
Same journal

YoLeTooth: A Unified Framework for Joint Tooth Segmentation and Periapical Lesion Detection in Panoramic Radiographs.

Journal of imaging·2026
Same journal

Radiomics-Guided Multi-Sequence Learning for Pathological Complete Response Prediction from Breast MRI with Missing Auxiliary Sequences.

Journal of imaging·2026
Same journal

Cutaneous Thermography in Arthropathies: Quantitative Imaging, Machine Learning, and Clinical Translation.

Journal of imaging·2026
Same journal

Two-Stage Dynamic Synergistic Segmentation Method for Myocardial Pathology.

Journal of imaging·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

949

Deep Learning-Based Diagnosis Algorithm for Alzheimer's Disease.

Zhenhao Jin1, Junjie Gong1, Minghui Deng1

  • 1College of Electrical and Information, Northeast Agricultural University, 600 Changjiang Road, Harbin 150038, China.

Journal of Imaging
|December 27, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces an AI-driven, two-stage algorithm for diagnosing Alzheimer's disease (AD) using brain MR images. The improved deep learning models achieved high accuracy, aiding in early and efficient AD detection.

Keywords:
Alzheimer’s diseaseMRIattention mechanismautomatic auxiliary diagnosisdeep learning

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

90
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Related Experiment Videos

Last Updated: Jun 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

949
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

90
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Area of Science:

  • Neuroimaging and Artificial Intelligence
  • Medical Diagnostics

Background:

  • Alzheimer's disease (AD) prevalence is increasing with the aging population.
  • Medical imaging and AI integration enhances brain disease diagnosis efficiency.
  • Current diagnostic methods require improvement for accuracy and speed.

Purpose of the Study:

  • To develop an innovative two-stage automatic auxiliary diagnosis algorithm for AD.
  • To improve the accuracy and efficiency of diagnosing Alzheimer's disease using brain MR images.
  • To leverage deep learning models for enhanced AD detection.

Main Methods:

  • An improved 3D DenseNet segmentation model and an improved MobileNetV3 classification model were utilized.
  • Modifications included backbone simplification, activation/loss function replacement, and integration of 3D GAM and CA attention mechanisms.
  • Dilated convolutions and transfer learning were employed to enhance feature extraction capabilities.

Main Results:

  • The proposed algorithm achieved high classification accuracies: 97.85% for AD/NC, 95.31% for MCI/NC, 93.96% for AD/MCI, and 92.63% for AD/MCI/NC.
  • Accuracy improvements ranged from 2.6 to 3.1 percentage points compared to the baseline models.
  • Comparative and ablation studies validated the superior classification performance.

Conclusions:

  • The developed deep learning-based algorithm offers an accurate and efficient automated auxiliary diagnosis for AD.
  • The enhanced segmentation and classification models demonstrate significant improvements in detecting AD and related cognitive impairments.
  • This approach provides a promising solution for early and reliable Alzheimer's disease diagnosis.